Acorda Therapeutics Cdt buy StockNews.com
Start price
22.12.23
/
50%
€0.47
Target price
22.12.24
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 22.12.24. The prediction end date can be changed by StockNews_com at any time.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acorda Therapeutics Cdt | - | - |
iShares Core DAX® | 3.178% | 0.980% |
iShares Nasdaq 100 | 2.972% | 0.925% |
iShares Nikkei 225® | 0.545% | -4.556% |
iShares S&P 500 | 2.367% | 0.833% |
Comments by StockNews_com for this prediction
In the thread Acorda Therapeutics Cdt diskutieren
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for ACOR provided by MarketBeat
Stopped prediction by StockNews_com for Acorda Therapeutics Cdt
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.58
31.05.23
31.05.23
-
31.05.24
31.05.24
-18.97%
02.06.23
02.06.23
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.61
07.05.23
07.05.23
-
07.05.24
07.05.24
-22.31%
08.05.24
08.05.24
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.41
29.04.23
29.04.23
-
29.04.24
29.04.24
10.78%
30.04.24
30.04.24